{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T18:28:48Z","timestamp":1767378528406,"version":"3.48.0"},"reference-count":80,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T00:00:00Z","timestamp":1767312000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"KESS2"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:p>\n                    Using visualisation to conceptualise a chronic condition can encourage accurate illness beliefs and support treatment adherence. Hi-BP is a digital visual intervention to support adherence to antihypertensive medication, co-produced with patients. The aim of this study was to investigate the feasibility and acceptability of Hi-BP and explore the preliminary direction of effects on illness and treatment beliefs, medication adherence and blood pressure (BP). A two-phased mixed-methods non-randomised feasibility study was conducted from April 2021 to March 2022 in eight community pharmacies across one Health Board in South-East Wales, UK. Hi-BP was delivered as a single researcher-led consultation to 69 patients in Phase 1 and by pharmacists to three patients in Phase 2. Feasibility was determined using predefined criteria, with acceptability explored qualitatively using semi-structured interviews. Quantitative outcome measures (\n                    <jats:italic>illness perceptions, medication beliefs, medication-adherence, prescription dispensing and collection data, BP)<\/jats:italic>\n                    were recorded at baseline and immediately post-intervention.Follow-up outcome measures were collected at two-weeks (\n                    <jats:italic>medication-adherence<\/jats:italic>\n                    ) and three-months (\n                    <jats:italic>all baseline measures<\/jats:italic>\n                    ). Hi-BP met feasibility criteria for pharmacist recruitment in both phases, and patient recruitment in Phase 1, but not Phase 2. Hi-BP was acceptable to the sub-sample of 15 patient participants interviewed in Phase 1; insufficient data were available to determine patient acceptability at Phase 2. Hi-BP was acceptable to pharmacists in Phase 1 and partially acceptable at Phase 2, due to competing demands on time for intervention delivery. All outcome measures were considered feasible for use, though a ceiling effect was noted for medication adherence. A potentially positive directional effect was found for illness perceptions (X\n                    <jats:sup>2<\/jats:sup>\n                    (2)=10.83,n=54,p=0.004), medication beliefs (BMQ-Necessity (X\n                    <jats:sup>2<\/jats:sup>\n                    (2)=11.71,n=54,p=0.003) and BP (Systolic BP Z=-3.91,n=51,p=&lt;0.001) but not for medication adherence (MARS-5 X\n                    <jats:sup>2<\/jats:sup>\n                    (2)= 2.4,n=45,p=0.299). In the Community Pharmacy setting, Hi-BP was well-accepted and has the potential for significant reductions in BP; however, further research is needed to explore pharmacist capacity to support implementation.\n                  <\/jats:p>","DOI":"10.1371\/journal.pone.0339871","type":"journal-article","created":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T18:24:28Z","timestamp":1767378268000},"page":"e0339871","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["Visualisation of hypertension: A non-randomised pilot study to explore the feasibility of a Community Pharmacy-based intervention to support medication adherence (Hi-BP)"],"prefix":"10.1371","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9741-1935","authenticated-orcid":true,"given":"Sarah L.","family":"Brown","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5912-1278","authenticated-orcid":true,"given":"Barry J.","family":"McDonnell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"McRae","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Angel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Imtiaz","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rhiannon","family":"Phillips","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Britt","family":"Hallingberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7434-7064","authenticated-orcid":true,"given":"Delyth H.","family":"James","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2026,1,2]]},"reference":[{"issue":"6","key":"pone.0339871.ref001","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1161\/HYPERTENSIONAHA.120.15026","article-title":"2020 International Society of Hypertension Global Hypertension Practice Guidelines","volume":"75","author":"T Unger","year":"2020","journal-title":"Hypertension"},{"issue":"9349","key":"pone.0339871.ref002","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/S0140-6736(02)11911-8","article-title":"Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies","volume":"360","author":"Prospective Studies Collaboration","year":"2002","journal-title":"Lancet"},{"issue":"10022","key":"pone.0339871.ref003","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/S0140-6736(15)01225-8","article-title":"Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis","volume":"387","author":"D Ettehad","year":"2016","journal-title":"Lancet"},{"issue":"12","key":"pone.0339871.ref004","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/S1474-4422(23)00420-9","article-title":"The global challenge of hypertension","volume":"22","author":"The Lancet Neurology","year":"2023","journal-title":"Lancet Neurol"},{"volume-title":"Global report on hypertension: the race against a silent killer","year":"2023","author":"World Health Organisation","key":"pone.0339871.ref005"},{"issue":"10199","key":"pone.0339871.ref006","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/S0140-6736(19)31145-6","article-title":"Long-term and recent trends in hypertension awareness, treatment, and control in 12 high-income countries: an analysis of 123 nationally representative surveys","volume":"394","author":"NCD Risk Factor Collaboration (NCD-RisC)","year":"2019","journal-title":"Lancet"},{"issue":"11","key":"pone.0339871.ref007","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.jash.2016.08.009","article-title":"The association between Self-Reported Medication Adherence scores and systolic blood pressure control: a SPRINT baseline data study","volume":"10","author":"WE Haley","year":"2016","journal-title":"J Am Soc Hypertens"},{"issue":"6","key":"pone.0339871.ref008","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s11606-009-1240-1","article-title":"Antihypertensive medication adherence, ambulatory visits, and risk of stroke and death","volume":"25","author":"JE Bailey","year":"2010","journal-title":"J Gen Intern Med"},{"issue":"4","key":"pone.0339871.ref009","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000005641","article-title":"Nonadherence to antihypertensive drugs: A systematic review and meta-analysis","volume":"96","author":"TM Abegaz","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"pone.0339871.ref010","article-title":"Global Burden, Regional Differences, Trends, and Health Consequences of Medication Nonadherence for Hypertension During 2010 to 2020: A Meta-Analysis Involving 27 Million Patients","volume":"11","author":"EKP Lee","year":"2022","journal-title":"J Am Heart Assoc"},{"volume-title":"Adherence to long-term therapies: Evidence for action","year":"2003","author":"E. Sabate\u0301","key":"pone.0339871.ref011"},{"key":"pone.0339871.ref012","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3389\/fphar.2013.00091","article-title":"Determinants of patient adherence: a review of systematic reviews","volume":"4","author":"P Kardas","year":"2013","journal-title":"Front Pharmacol"},{"issue":"4","key":"pone.0339871.ref013","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1136\/ejhpharm-2018-001725","article-title":"Medication adherence interventions and outcomes: an overview of systematic reviews","volume":"26","author":"NC Wilhelmsen","year":"2019","journal-title":"Eur J Hosp Pharm"},{"issue":"11","key":"pone.0339871.ref014","article-title":"Interventions for enhancing medication adherence","volume":"2014","author":"R Nieuwlaat","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"pone.0339871.ref015","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1080\/17437199.2010.537592","article-title":"Improving patient adherence: a three-factor model to guide practice","volume":"6","author":"MR DiMatteo","year":"2012","journal-title":"Health Psychology Review"},{"issue":"8","key":"pone.0339871.ref016","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.jval.2014.08.2671","article-title":"Predicting adherence to medications using health psychology theories: a systematic review of 20 years of empirical research","volume":"17","author":"EAF Holmes","year":"2014","journal-title":"Value Health"},{"issue":"2","key":"pone.0339871.ref017","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.gerinurse.2012.01.006","article-title":"Medication beliefs and antihypertensive adherence among older adults: a pilot study","volume":"33","author":"TM Ruppar","year":"2012","journal-title":"Geriatr Nurs"},{"issue":"6","key":"pone.0339871.ref018","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.pec.2019.02.022","article-title":"Health beliefs and medication adherence in patients with hypertension: A systematic review of quantitative studies","volume":"102","author":"H Al-Noumani","year":"2019","journal-title":"Patient Educ Couns"},{"issue":"7","key":"pone.0339871.ref019","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1161\/CIRCRESAHA.118.313220","article-title":"Adherence in Hypertension","volume":"124","author":"M Burnier","year":"2019","journal-title":"Circ Res"},{"issue":"9","key":"pone.0339871.ref020","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/sj.jhh.1001721","article-title":"Patient compliance in hypertension: role of illness perceptions and treatment beliefs","volume":"18","author":"S Ross","year":"2004","journal-title":"J Hum Hypertens"},{"issue":"4","key":"pone.0339871.ref021","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.jvn.2012.04.002","article-title":"Factors affecting medication adherence in patients with hypertension","volume":"30","author":"P Karakurt","year":"2012","journal-title":"J Vasc Nurs"},{"issue":"8","key":"pone.0339871.ref022","doi-asserted-by":"crossref","first-page":"3239","DOI":"10.1016\/j.sapharm.2021.11.006","article-title":"The effect of visual interventions on illness beliefs and medication adherence for chronic conditions: A scoping review of the literature and mapping to behaviour change techniques (BCTs)","volume":"18","author":"SL Brown","year":"2022","journal-title":"Res Social Adm Pharm"},{"issue":"4","key":"pone.0339871.ref023","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1111\/bjhp.12080","article-title":"Seeing what\u2019s happening on the inside: patients\u2019 views of the value of diagnostic cardiac computed tomography angiography","volume":"19","author":"DA Devcich","year":"2014","journal-title":"Br J Health Psychol"},{"issue":"1","key":"pone.0339871.ref024","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1007\/s12160-015-9736-x","article-title":"Using Animation to Improve Recovery from Acute Coronary Syndrome: A Randomized Trial","volume":"50","author":"ASK Jones","year":"2016","journal-title":"Ann Behav Med"},{"issue":"2","key":"pone.0339871.ref025","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.pec.2005.05.004","article-title":"The role of pictures in improving health communication: a review of research on attention, comprehension, recall, and adherence","volume":"61","author":"PS Houts","year":"2006","journal-title":"Patient Educ Couns"},{"issue":"5","key":"pone.0339871.ref026","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1007\/s12160-017-9895-z","article-title":"Can Communicating Personalised Disease Risk Promote Healthy Behaviour Change? A Systematic Review of Systematic Reviews","volume":"51","author":"DP French","year":"2017","journal-title":"Ann Behav Med"},{"issue":"1","key":"pone.0339871.ref027","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s12160-013-9486-6","article-title":"The behavior change technique taxonomy (v1) of 93 hierarchically clustered techniques: building an international consensus for the reporting of behavior change interventions","volume":"46","author":"S Michie","year":"2013","journal-title":"Ann Behav Med"},{"key":"pone.0339871.ref028","article-title":"A new framework for developing and evaluating complex interventions: update of Medical Research Council guidance","volume":"374","author":"K Skivington","year":"2021","journal-title":"BMJ"},{"key":"pone.0339871.ref029","first-page":"7","article-title":"The common sense representation of illness danger.","volume-title":"Contributions to Medical Psychology","author":"H Leventhal","year":"1980","edition":"1"},{"key":"pone.0339871.ref030","first-page":"42","article-title":"The common-sense model of self-regulation of health and illness.","volume-title":"The self-regulation of health and illness behaviour","author":"H Leventhal","year":"2003"},{"issue":"6","key":"pone.0339871.ref031","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1007\/s10865-016-9782-2","article-title":"The Common-Sense Model of Self-Regulation (CSM): a dynamic framework for understanding illness self-management","volume":"39","author":"H Leventhal","year":"2016","journal-title":"J Behav Med"},{"issue":"6","key":"pone.0339871.ref032","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S0022-3999(99)00057-4","article-title":"Patients\u2019 beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness","volume":"47","author":"R Horne","year":"1999","journal-title":"J Psychosom Res"},{"issue":"3","key":"pone.0339871.ref033","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0150205","article-title":"Defining Feasibility and Pilot Studies in Preparation for Randomised Controlled Trials: Development of a Conceptual Framework","volume":"11","author":"SM Eldridge","year":"2016","journal-title":"PLoS One"},{"issue":"3","key":"pone.0339871.ref034","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/s11096-017-0462-2","article-title":"Abstracts PCNE working conference 2017. Bled, Slovenia. 1\u20133 February 2017","volume":"39","year":"2017","journal-title":"Int J Clin Pharm"},{"issue":"7","key":"pone.0339871.ref035","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/j.sapharm.2020.09.013","article-title":"Pharmacist-led transitions of care for older adults at risk of drug-related problems: A feasibility study","volume":"17","author":"B Cossette","year":"2021","journal-title":"Res Social Adm Pharm"},{"issue":"1","key":"pone.0339871.ref036","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s40814-020-00762-3","article-title":"A non-randomised pilot study of the Solutions for Medication Adherence Problems (S-MAP) intervention in community pharmacies to support older adults adhere to multiple medications","volume":"7","author":"DE Patton","year":"2021","journal-title":"Pilot Feasibility Stud"},{"key":"pone.0339871.ref037","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s40814-015-0026-y","article-title":"Maximising the impact of qualitative research in feasibility studies for randomised controlled trials: guidance for researchers","volume":"1","author":"A O\u2019Cathain","year":"2015","journal-title":"Pilot Feasibility Stud"},{"issue":"6","key":"pone.0339871.ref038","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.jpsychores.2005.10.020","article-title":"The brief illness perception questionnaire","volume":"60","author":"E Broadbent","year":"2006","journal-title":"J Psychosom Res"},{"issue":"1","key":"pone.0339871.ref039","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/08870449908407311","article-title":"The beliefs about medicines questionnaire: The development and evaluation of a new method for assessing the cognitive representation of medication","volume":"14","author":"R Horne","year":"1999","journal-title":"Psychology & Health"},{"issue":"5","key":"pone.0339871.ref040","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1111\/j.1365-2125.2012.04167.x","article-title":"A new taxonomy for describing and defining adherence to medications","volume":"73","author":"B Vrijens","year":"2012","journal-title":"Br J Clin Pharmacol"},{"issue":"7","key":"pone.0339871.ref041","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1111\/bcp.14193","article-title":"The Medication Adherence Report Scale: A measurement tool for eliciting patients\u2019 reports of nonadherence","volume":"86","author":"AHY Chan","year":"2020","journal-title":"Br J Clin Pharmacol"},{"volume-title":"Blood pressure measurement using automated blood pressure monitors","year":"2025","author":"British and Irish Hypertension Society","key":"pone.0339871.ref042"},{"key":"pone.0339871.ref043","first-page":"426","article-title":"Doing template analysis.","volume-title":"Qualitative organizational research","author":"N. King","year":"2012"},{"key":"pone.0339871.ref044","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/bjhp.12295","article-title":"Acceptability of health care interventions: A theoretical framework and proposed research agenda","volume":"23","author":"M Sekhon","year":"2018","journal-title":"Br J Health Psychol"},{"unstructured":"StatsWales. Prescription items and costs by cluster deprivation quintiles. https:\/\/statswales.gov.wales\/Catalogue\/Health-and-Social-Care\/NHS-Primary-and-Community-Activity\/Prescribing\/itemsprescribedandnetingredientcost-by-clusterdeprivation. Accessed 2025 March 5.","key":"pone.0339871.ref045"},{"key":"pone.0339871.ref046","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0223615","article-title":"Attending to design when developing complex health interventions: A qualitative interview study with intervention developers and associated stakeholders","volume":"14","author":"N Rousseau","year":"2019","journal-title":"PLoS One"},{"issue":"5","key":"pone.0339871.ref047","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1093\/tbm\/ibaa020","article-title":"A systematic review of interventions using health behavioral theories to improve medication adherence among patients with hypertension","volume":"10","author":"M Nili","year":"2020","journal-title":"Transl Behav Med"},{"issue":"6","key":"pone.0339871.ref048","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1345\/aph.1L663","article-title":"The adherence support gap: the \u201cideal\u201d versus \u201creality\u201d of antiretroviral adherence support provided by HIV health providers in clinical practice","volume":"43","author":"LY Park-Wyllie","year":"2009","journal-title":"Ann Pharmacother"},{"issue":"1","key":"pone.0339871.ref049","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1007\/s11096-013-9840-6","article-title":"Pharmacists\u2019 attitudes and perceived barriers to provision of adherence support in Australia","volume":"36","author":"SM Mansoor","year":"2014","journal-title":"Int J Clin Pharm"},{"issue":"3","key":"pone.0339871.ref050","first-page":"609","article-title":"Helpful advice and hidden expertize: pharmacy users\u2019 experiences of community pharmacy accessibility","volume":"39","author":"L Lindsey","year":"2017","journal-title":"J Public Health (Oxf)"},{"issue":"5","key":"pone.0339871.ref051","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2014-007328","article-title":"Access all areas? An area-level analysis of accessibility to general practice and community pharmacy services in England by urbanity and social deprivation","volume":"5","author":"A Todd","year":"2015","journal-title":"BMJ Open"},{"unstructured":"Duxbury K, Fisher K. Public perceptions of community pharmacy. https:\/\/www.ipsos.com\/en-uk\/public-perceptions-community-pharmacy. 2023.","key":"pone.0339871.ref052"},{"issue":"4","key":"pone.0339871.ref053","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/ijpp.12301","article-title":"Management of hypertension in an Australian community pharmacy setting - patients\u2019 beliefs and perspectives","volume":"25","author":"BV Bajorek","year":"2017","journal-title":"Int J Pharm Pract"},{"issue":"686","key":"pone.0339871.ref054","doi-asserted-by":"crossref","DOI":"10.3399\/bjgp19X705101","article-title":"Patient preferences for management of high blood pressure in the UK: a discrete choice experiment","volume":"69","author":"B Fletcher","year":"2019","journal-title":"Br J Gen Pract"},{"issue":"3","key":"pone.0339871.ref055","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0152257","article-title":"Managing Minor Ailments; The Public\u2019s Preferences for Attributes of Community Pharmacies. A Discrete Choice Experiment","volume":"11","author":"T Porteous","year":"2016","journal-title":"PLoS One"},{"issue":"4","key":"pone.0339871.ref056","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.amepre.2022.04.023","article-title":"Stakeholders\u2019 Acceptability of Pharmacist-Led Screening in Community Pharmacies: A Systematic Review","volume":"63","author":"S El-Den","year":"2022","journal-title":"Am J Prev Med"},{"issue":"17","key":"pone.0339871.ref057","doi-asserted-by":"crossref","DOI":"10.1093\/ajhp\/zxaf010","article-title":"Utilizing pharmacy technicians for medication adherence patient outreach in an ambulatory care setting","volume":"82","author":"B Carqueville","year":"2025","journal-title":"Am J Health Syst Pharm"},{"issue":"4","key":"pone.0339871.ref058","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-053455","article-title":"Approaches and outcomes of community health worker\u2019s interventions for hypertension management and control in low-income and middle-income countries: systematic review","volume":"12","author":"GW Mbuthia","year":"2022","journal-title":"BMJ Open"},{"key":"pone.0339871.ref059","first-page":"100549","article-title":"Optimizing work in community pharmacy: What preferences do community pharmacists and pharmacy technicians have for a better allocation of daily activities?","volume":"17","author":"J-D Bardet","year":"2024","journal-title":"Explor Res Clin Soc Pharm"},{"unstructured":"Mackridge A, Williams E. Clinical Community Pharmacy Service: Service specification for the Clinical Community Pharmacy Service in Wales. 2025. https:\/\/nwssp.nhs.wales\/ourservices\/primary-care-services\/primary-care-services-documents\/ccps-documents\/ccps-service-spec-v22-valid-wef-01022025\/","key":"pone.0339871.ref060"},{"unstructured":"NHS W. Help me quit @ pharmacy service specification. 2020. https:\/\/cpwales.org.uk\/wp-content\/uploads\/2022\/11\/Help-Me-Quit-@-Pharmacy-Service-Specification-31-Jan-2020-1.pdf","key":"pone.0339871.ref061"},{"unstructured":"Community Pharmacy England. MUR statistics - Archive information. https:\/\/cpe.org.uk\/funding-and-reimbursement\/nhs-statistics\/mur-statistics\/. Accessed 2025 March 9.","key":"pone.0339871.ref062"},{"year":"2021","author":"Welsh Government","key":"pone.0339871.ref063"},{"issue":"2","key":"pone.0339871.ref064","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1136\/bmjqs-2020-011671","article-title":"Effectiveness of a medication adherence management intervention in a community pharmacy setting: a cluster randomised controlled trial","volume":"31","author":"A Torres-Robles","year":"2022","journal-title":"BMJ Qual Saf"},{"issue":"2","key":"pone.0339871.ref065","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/jep.13451","article-title":"Community pharmacist interventions to improve adherence to lipid lowering medication and their influence on clinical outcomes: A systematic review and meta-analysis","volume":"27","author":"A O\u00f1atibia-Astibia","year":"2021","journal-title":"J Eval Clin Pract"},{"issue":"10","key":"pone.0339871.ref066","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1016\/j.sapharm.2021.01.013","article-title":"The influence of intervention complexity on barriers and facilitators in the implementation of professional pharmacy services - A systematic review","volume":"17","author":"R Moecker","year":"2021","journal-title":"Res Social Adm Pharm"},{"key":"pone.0339871.ref067","first-page":"217047","article-title":"Medication Adherence Measures: An Overview","volume":"2015","author":"WY Lam","year":"2015","journal-title":"Biomed Res Int"},{"key":"pone.0339871.ref068","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.2147\/PPA.S127131","article-title":"Coming full circle in the measurement of medication adherence: opportunities and implications for health care","volume":"11","author":"E Whalley Buono","year":"2017","journal-title":"Patient Prefer Adherence"},{"issue":"4","key":"pone.0339871.ref069","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1007\/s13142-015-0315-2","article-title":"Self-report measures of medication adherence behavior: recommendations on optimal use","volume":"5","author":"MJ Stirratt","year":"2015","journal-title":"Transl Behav Med"},{"issue":"7","key":"pone.0339871.ref070","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1016\/j.pec.2017.02.001","article-title":"Medication adherence: A practical measurement selection guide using case studies","volume":"100","author":"LL Zullig","year":"2017","journal-title":"Patient Educ Couns"},{"key":"pone.0339871.ref071","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jclinepi.2017.07.011","article-title":"Congruence between patient characteristics and interventions may partly explain medication adherence intervention effectiveness: an analysis of 190 randomized controlled trials from a Cochrane systematic review","volume":"91","author":"SS Allemann","year":"2017","journal-title":"J Clin Epidemiol"},{"issue":"10","key":"pone.0339871.ref072","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1177\/1049732307308761","article-title":"A practical guide to the e-mail interview","volume":"17","author":"N Hunt","year":"2007","journal-title":"Qual Health Res"},{"author":"L Gibson","journal-title":"Collecting Qualitative Data","article-title":"\u2018Type Me Your Answer\u2019","key":"pone.0339871.ref073"},{"unstructured":"NHS England. NHS community pharmacy hypertension case-finding advanced service (NHS community pharmacy blood pressure check service). 2023. https:\/\/www.england.nhs.uk\/wp-content\/uploads\/2021\/11\/PRN00173-adv-service-spec-nhs-community-pharmacy-hypertension-case-finding-advanced-service-v2.3.pdf","key":"pone.0339871.ref074"},{"unstructured":"NHS England. Advanced service specification \u2013 NHS new medicine service (NMS). 2021. https:\/\/www.england.nhs.uk\/publication\/advanced-service-specification-nhs-new-medicine-service-nms\/","key":"pone.0339871.ref075"},{"unstructured":"May Measure Month. https:\/\/www.maymeasure.org\/. Accessed 2025 March 9.","key":"pone.0339871.ref076"},{"issue":"1","key":"pone.0339871.ref077","doi-asserted-by":"crossref","first-page":"2265132","DOI":"10.1080\/08037051.2023.2265132","article-title":"European Society of Hypertension - general practitioners\u2019 program hypertension management: focus on general practice","volume":"32","author":"de Pinho R","year":"2023","journal-title":"Blood Press"},{"issue":"3","key":"pone.0339871.ref078","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/s41371-018-0147-x","article-title":"Physician-pharmacist collaborative practice and telehealth may transform hypertension management","volume":"33","author":"S Omboni","year":"2019","journal-title":"J Hum Hypertens"},{"issue":"1","key":"pone.0339871.ref079","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/bcp.14164","article-title":"Impact of the pharmacist-led intervention on the control of medical cardiovascular risk factors for the primary prevention of cardiovascular disease in general practice: A systematic review and meta-analysis of randomised controlled trials","volume":"86","author":"AA Alshehri","year":"2020","journal-title":"Br J Clin Pharmacol"},{"issue":"11","key":"pone.0339871.ref080","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.clinthera.2023.08.011","article-title":"Patient Adherence to Secondary Prevention Therapies After an Acute Coronary Syndrome: A Scoping Review","volume":"45","author":"MC Bahit","year":"2023","journal-title":"Clin Ther"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0339871","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T18:24:39Z","timestamp":1767378279000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0339871"}},"subtitle":[],"editor":[{"given":"Usman Rashid","family":"Malik","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2026,1,2]]},"references-count":80,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1,2]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0339871","relation":{},"ISSN":["1932-6203"],"issn-type":[{"type":"electronic","value":"1932-6203"}],"subject":[],"published":{"date-parts":[[2026,1,2]]}}}